Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Healthtrust
Citi
Novartis
Daiichi Sankyo
Queensland Health
Merck
Express Scripts
Boehringer Ingelheim

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074505

« Back to Dashboard

NDA 074505 describes CAPTOPRIL, which is a drug marketed by Apotex, Apothecon, Boscogen, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan Pharms Inc, Par Pharm, Prinston Inc, Purepac Pharm, Sandoz, Teva, Vintage Pharms Llc, Watson Labs, Wockhardt Ltd, Yaopharma Co Ltd, Ivax Sub Teva Pharms, and Mylan, and is included in twenty-eight NDAs. It is available from twenty-eight suppliers. Additional details are available on the CAPTOPRIL profile page.

The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
Summary for 074505
Tradename:CAPTOPRIL
Applicant:Hikma Intl Pharms
Ingredient:captopril
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074505
Medical Subject Heading (MeSH) Categories for 074505
Suppliers and Packaging for NDA: 074505
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAPTOPRIL captopril TABLET;ORAL 074505 ANDA West-Ward Pharmaceuticals Corp 0143-1171 N 0143-1171-10
CAPTOPRIL captopril TABLET;ORAL 074505 ANDA West-Ward Pharmaceuticals Corp 0143-1171 N 0143-1171-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG
Approval Date:Feb 13, 1996TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Feb 13, 1996TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Feb 13, 1996TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
Citi
US Department of Justice
Teva
McKesson
Moodys
US Army
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot